Key risk indicators (KRIs) are commonly used as an important component of central monitoring to enable study teams to detect emerging quality issues of interest during a clinical trial. Given the large volume of KRI-related information now available for global clinical trials on the CluePoints risk-based quality management (RBQM) platform, we decided to take the opportunity to assess to what degree this KRI data provides evidence of the disruption of the war in Ukraine to clinical research being conducted there.
